DexCom, Inc. (DXCM) Analysts See $-0.14 EPS; OCEANGOLD CORPORATION COMMON (OCANF) Shorts Up By 69.95%

June 30, 2017 - By Henry Gaston

OCEANGOLD CORPORATION COMMON (OTCMKTS:OCANF) had an increase of 69.95% in short interest. OCANF’s SI was 2.62M shares in June as released by FINRA. Its up 69.95% from 1.54 million shares previously. With 171,900 avg volume, 15 days are for OCEANGOLD CORPORATION COMMON (OTCMKTS:OCANF)’s short sellers to cover OCANF’s short positions. It closed at $3.1 lastly. It is down 0.00% since June 30, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts expect DexCom, Inc. (NASDAQ:DXCM) to report $-0.14 EPS on August, 1.They anticipate $0.10 EPS change or 41.67% from last quarter’s $-0.24 EPS. After having $-0.49 EPS previously, DexCom, Inc.’s analysts see -71.43% EPS growth. About shares traded. DexCom, Inc. (NASDAQ:DXCM) has risen 9.41% since June 30, 2016 and is uptrending. It has underperformed by 7.29% the S&P500.

OceanaGold Corporation is a gold mining company. The company has market cap of $1.91 billion. The Firm is engaged in the exploration, development and operation of gold and other mineral mining activities. It has a 12.92 P/E ratio. The Company’s divisions are New Zealand, the Philippines, the United States and All other divisions.

Among 15 analysts covering Dexcom (NASDAQ:DXCM), 13 have Buy rating, 0 Sell and 2 Hold. Therefore 87% are positive. Dexcom had 22 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was initiated by Morgan Stanley with “Overweight” on Monday, November 2. The firm earned “Neutral” rating on Wednesday, September 14 by BTIG Research. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Tuesday, January 3 report. JP Morgan maintained the stock with “Overweight” rating in Wednesday, February 24 report. The firm has “Outperform” rating by Leerink Swann given on Thursday, October 15. The stock has “Buy” rating by BTIG Research on Monday, October 31. The firm has “Overweight” rating given on Monday, May 22 by PiperJaffray. Canaccord Genuity maintained the shares of DXCM in report on Wednesday, November 2 with “Buy” rating. As per Friday, July 15, the company rating was maintained by Deutsche Bank. The stock has “Overweight” rating by JP Morgan on Thursday, September 17.

Investors sentiment increased to 1.37 in 2016 Q4. Its up 0.27, from 1.1 in 2016Q3. It increased, as 43 investors sold DexCom, Inc. shares while 81 reduced holdings. 68 funds opened positions while 102 raised stakes. 92.29 million shares or 4.94% more from 87.94 million shares in 2016Q3 were reported. Citadel Advisors Ltd Company has invested 0% in DexCom, Inc. (NASDAQ:DXCM). Great West Life Assurance Communication Can invested 0% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Waddell Reed Fincl Incorporated holds 0.14% or 1.09M shares in its portfolio. Cubist Systematic Strategies Ltd Liability Corp has invested 0.32% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Tocqueville Asset L P invested in 12,979 shares. 16,104 are held by Stifel Corporation. Westwood Il owns 25,000 shares or 0.29% of their US portfolio. 501,683 are owned by State Common Retirement Fund. The California-based Cap Ww Investors has invested 0% in DexCom, Inc. (NASDAQ:DXCM). State Street Corp reported 0.01% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Ironbridge Capital Mngmt L P accumulated 80,937 shares or 0.22% of the stock. Massachusetts Finance Ma accumulated 326,797 shares. Envestnet Asset Mgmt Incorporated holds 17,860 shares. 12,015 were accumulated by King Luther Capital Mngmt. Fiera Capital reported 550,037 shares.

Dexcom, Inc. is a medical device company. The company has market cap of $6.15 billion. The Firm is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. It currently has negative earnings. The Company’s products consist of DexCom G4 PLATINUM and DexCom G5 Mobile.